Dr Vishal R Tandon nominated as expert at CDSCO

The Central Drugs Standard Control Organisation (CDSCO)under Directorate General of Health Services,Ministry of Health & Family Welfare, Government of India is the National Regulatory Authority (NRA) of India.

Under the Drugs and Cosmetics Act, CDSCO is responsible for approval of Drugs, Conduct of Clinical Trials, laying down the standards for Drugs, control over the quality of imported Drugs in the country and coordination of the activities of State Drug Control Organizations by providing expert advice with a view of bring about the uniformity in the enforcement of the Drugs and Cosmetics Act.

Further CDSCO along with state regulators, is jointly responsible for grant of licenses of certain specialized categories of critical Drugs such as blood and blood products, I. V. Fluids, Vaccine and Sera.

Daily Excelsior reports that Prof Tandon, along with seven other members, has been nominated as a national expert from JnK.

They'll be evaluating and advising the Drug Controller General of India (DCGI) on proposals for approval of new drugs, investigational new drugs, and cellular biology-based drug products at the national level, as per rule 100 of the New Drugs & Clinical Trials Rules, 2019, with approval of the Ministry.

The rule 100 of the New Drugs & Clinical Trials Rules, 2019 says, "The Central Licencing Authority may, when so required, constitute one or more expert committee or group of experts with specialisation in relevant fields, with the approval of Central Government, to evaluate scientific and technical matters relating to drugs and such committee or group may, give its recommendations to that authority on matters referred to it within a period of sixty days from the date of reference."